Discovery and validation of Hsa-microRNA-3665 promoter methylation as a potential biomarker for the prognosis of esophageal squaous cell carcinoma
High hsa-miR-3665 promoter methylation levels may be a potential biomarker for the progression of ESCC.
Authors
- Qiaoyan Zeng
- Rong Fu (ORCID: https://orcid.org/0000-0002-2850-1697)
- Zheng Lin (ORCID: https://orcid.org/0000-0001-5242-716X)
- Juwei Zhang (ORCID: https://orcid.org/0000-0001-6603-1932)
- Yulan Lin (ORCID: https://orcid.org/0000-0002-4208-9408)
- Shuang Liu (ORCID: https://orcid.org/0000-0001-9347-7104)
- Zhijian Hu (ORCID: https://orcid.org/0000-0003-1334-5334)
- Jinsong Zhou
Institutions
- Fujian Medical University (CN)
- Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- International Journal of Clinical Oncology
- Published
- 2024-12-04
- DOI
- https://doi.org/10.1007/s10147-024-02656-3
- Citations
- 2
- Primary Topic
- Cancer-related gene regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.47
Funders
- Natural Science Foundation of Fujian Province
- Fujian Medical University